| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-585-30 | 67877-585 | HUMAN PRESCRIPTION DRUG | Eslicarbazepine Acetate | Eslicarbazepine Acetate | TABLET | ORAL | 20250506 | N/A | ANDA | ANDA211199 | Ascend Laboratories, LLC | ESLICARBAZEPINE ACETATE | 200 mg/1 | 30 TABLET in 1 BOTTLE (67877-585-30) |
| 67877-586-30 | 67877-586 | HUMAN PRESCRIPTION DRUG | Eslicarbazepine Acetate | Eslicarbazepine Acetate | TABLET | ORAL | 20250506 | N/A | ANDA | ANDA211199 | Ascend Laboratories, LLC | ESLICARBAZEPINE ACETATE | 400 mg/1 | 30 TABLET in 1 BOTTLE (67877-586-30) |
| 67877-587-60 | 67877-587 | HUMAN PRESCRIPTION DRUG | Eslicarbazepine Acetate | Eslicarbazepine Acetate | TABLET | ORAL | 20250506 | N/A | ANDA | ANDA211199 | Ascend Laboratories, LLC | ESLICARBAZEPINE ACETATE | 600 mg/1 | 60 TABLET in 1 BOTTLE (67877-587-60) |
| 67877-588-30 | 67877-588 | HUMAN PRESCRIPTION DRUG | Eslicarbazepine Acetate | Eslicarbazepine Acetate | TABLET | ORAL | 20250506 | N/A | ANDA | ANDA211199 | Ascend Laboratories, LLC | ESLICARBAZEPINE ACETATE | 800 mg/1 | 30 TABLET in 1 BOTTLE (67877-588-30) |